tiprankstipranks
Trending News
More News >
Rcm Technologies (RCMT)
NASDAQ:RCMT
Advertisement

Rcm Technologies (RCMT) AI Stock Analysis

Compare
186 Followers

Top Page

RCMT

Rcm Technologies

(NASDAQ:RCMT)

Rating:64Neutral
Price Target:
$24.50
▼(-0.61% Downside)
Rcm Technologies' strong earnings call performance, highlighting growth in key segments and improved financial metrics, is the most significant factor contributing to its score. The company's operational efficiency and reasonable valuation further support its position. However, technical indicators suggest a neutral trend, and the lack of financial leverage could limit future growth potential.
Positive Factors
Business Expansion
New business pipelines are expanding, particularly in Specialty Healthcare and Engineering, with Aerospace on track for a record year.
Growth Potential
RCM Technologies is tracking for double-digit growth, with strong performances in its largest segments, Specialty Healthcare and Engineering.
Negative Factors
Profitability Issues
The 4Q gross profit was negatively impacted by a lower gross margin in Engineering Services due to a higher mix of lower margin engagements and one-time issues.
Revenue Challenges
There was a 9% decline in Life Sciences, Data & Solutions revenue due to project timing and a deemphasis of the legacy staffing business.

Rcm Technologies (RCMT) vs. SPDR S&P 500 ETF (SPY)

Rcm Technologies Business Overview & Revenue Model

Company DescriptionRCM Technologies, Inc. (RCMT) is a professional services firm that provides a range of technology and consulting services primarily to the healthcare, engineering, and information technology sectors. The company specializes in delivering tailored solutions that include IT staffing, project management, systems integration, and business process outsourcing. RCM Technologies leverages its expertise to support clients in enhancing operational efficiencies and achieving their strategic objectives.
How the Company Makes MoneyRCM Technologies generates revenue primarily through service contracts and consulting engagements. The company earns money by providing IT staffing services, where it charges clients a fee based on the hourly rates of the professionals placed in various projects. Additionally, RCM Technologies derives income from project-based consulting services, which involve fixed-fee or time-and-materials billing arrangements. The company may also benefit from long-term contracts with healthcare and engineering firms, ensuring a stable income stream. Strategic partnerships with technology providers and industry leaders enhance its service offerings and can lead to increased project opportunities, further contributing to its revenue.

Rcm Technologies Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: 3.31%|
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong growth and achievements, particularly in the Health Care and Aerospace segments, improved financial performance, and inclusion in a major growth index. However, challenges such as weak operating cash flow and volatile engineering gross margins were noted. Overall, the positive aspects significantly outweigh the challenges.
Q2-2025 Updates
Positive Updates
Inclusion in Russell 2000 Growth Index
RCM Technologies was included in the Russell 2000 Growth Index for the first time in its 50-year history, highlighting the company's growth and strength.
Strong Growth in Health Care Services Group
The Health Care Services Group closed the 2024/2025 school year with strong growth, expanding its roster of school partners and winning contracts from competitors.
Successful Aerospace and Defense Performance
The Aerospace and Defense Group exceeded business plan goals by almost $3 million in revenue, with a significant year-over-year increase in gross margin and EBITDA.
Improved Financial Performance
Consolidated gross profit for Q2 2025 was $22.3 million, growing 11.4% over Q2 2024. Adjusted EBITDA for Q2 2025 was $8.1 million, a growth of 12.9%, and adjusted EPS increased by 21.1%.
Engineering Segment Achievements
Engineering gross profit for Q2 2025 was $6.5 million, an 8.8% increase and the best quarter in the company's history, indicating strong performance in the segment.
Negative Updates
Weak Operating Cash Flow
Operating cash flow was weak for the quarter, partly due to a delay in receiving over $10 million from two major school clients.
Volatile Engineering Gross Margins
Engineering gross margin for Q2 2025 was 24.5%, compared to 26.5% for Q2 2024, and is expected to remain volatile.
Company Guidance
During the call, RCM Technologies provided robust guidance across its operating segments, highlighting key metrics that demonstrate growth and strategic advancements. The company reported a consolidated gross profit of $22.3 million for Q2 2025, reflecting an 11.4% increase from Q2 2024, and achieved its highest gross profit in the past 13 quarters. Adjusted EBITDA grew 12.9% to $8.1 million, and adjusted EPS increased by 21.1% to $0.69. The Health Care segment showed significant growth, with Q2 2025 gross profit rising 15.4% to $12.3 million and school revenue increasing by 21.1% to $37.2 million. Engineering gross profit rose by 8.8% to $6.5 million, marking the best quarterly performance in its history, despite a slight decline in gross margin from 26.5% to 24.5%. Additionally, IT, Life Sciences, and Data Solutions experienced a 3.4% increase in gross profit, reaching $3.5 million, with an improvement in gross margin from 34.9% to 39.8%. The company also anticipates at least low double-digit growth in adjusted EBITDA for the second half of fiscal 2025, with Q4 2025 expected to deliver the highest adjusted EBITDA for the year.

Rcm Technologies Financial Statement Overview

Summary
Rcm Technologies demonstrates operational efficiency with strong EBIT and EBITDA margins, despite a decrease in revenue and net income. The balance sheet shows no leverage, possibly limiting growth potential, while cash flows remain positive, indicating adequate liquidity management.
Income Statement
70
Positive
Rcm Technologies shows a stable gross profit margin and a positive EBIT margin in the TTM, with a slight decrease in net profit and revenue compared to the previous year. Despite this, the EBIT and EBITDA margins remain healthy, indicating operational efficiency.
Balance Sheet
45
Neutral
The balance sheet reveals a significant drop in stockholders' equity and no reported debt in the TTM, which indicates a zero debt-to-equity ratio. However, this could reflect a lack of financial leverage, potentially limiting growth. The equity ratio has decreased, impacting financial stability.
Cash Flow
65
Positive
The cash flow statement indicates a decline in free cash flow but a positive operating cash flow to net income ratio. While free cash flow has decreased, the company maintains a positive cash flow from operations, which is crucial for sustaining business operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue290.91M278.38M263.24M284.68M203.88M150.41M
Gross Profit81.39M79.78M76.70M82.93M53.12M38.85M
EBITDA25.20M24.51M24.51M29.53M6.97M-9.89M
Net Income13.56M13.33M16.83M20.89M10.99M-8.87M
Balance Sheet
Total Assets120.99M132.08M120.48M87.96M72.85M68.34M
Cash, Cash Equivalents and Short-Term Investments5.18M4.73M6.28M339.00K235.00K734.00K
Total Debt30.45M42.18M34.00M13.76M18.22M16.77M
Total Liabilities86.39M98.59M94.69M56.00M46.88M46.10M
Stockholders Equity34.60M33.48M25.79M31.96M25.97M22.24M
Cash Flow
Free Cash Flow14.07M3.60M9.55M27.55M347.00K24.74M
Operating Cash Flow16.40M6.17M12.48M28.44M915.00K25.20M
Investing Cash Flow-2.33M-2.57M-2.54M-4.98M6.29M-419.00K
Financing Cash Flow-10.70M-4.83M-3.85M-23.13M-7.55M-25.63M

Rcm Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price24.65
Price Trends
50DMA
24.18
Positive
100DMA
21.46
Positive
200DMA
21.08
Positive
Market Momentum
MACD
-0.06
Negative
RSI
53.22
Neutral
STOCH
82.40
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RCMT, the sentiment is Positive. The current price of 24.65 is above the 20-day moving average (MA) of 24.47, above the 50-day MA of 24.18, and above the 200-day MA of 21.08, indicating a bullish trend. The MACD of -0.06 indicates Negative momentum. The RSI at 53.22 is Neutral, neither overbought nor oversold. The STOCH value of 82.40 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RCMT.

Rcm Technologies Risk Analysis

Rcm Technologies disclosed 5 risk factors in its most recent earnings report. Rcm Technologies reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks
1.
Item Q4, 2024

Rcm Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
$183.11M13.9641.02%11.01%-15.44%
63
Neutral
$10.80B16.806.58%2.07%2.49%-15.77%
56
Neutral
$121.72M-21.54%-9.86%1.22%
47
Neutral
$110.36M-27.32%-19.00%48.70%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RCMT
Rcm Technologies
24.65
5.58
29.26%
NNBR
NN
2.30
-1.33
-36.64%
TUSK
Mammoth Energy Services
2.24
-1.54
-40.74%

Rcm Technologies Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
RCM Technologies Approves Performance Stock Units Grant
Neutral
May 7, 2025

On May 6, 2025, RCM Technologies’ Compensation Committee approved grants of up to 2,904 performance stock units to Michael Saks, Division President of Health Care Services, under the company’s 2014 Omnibus Equity Compensation Plan. The vesting of these units is contingent upon the achievement of specific operating income levels during the performance period from December 29, 2024, to January 3, 2026, with provisions for accelerated vesting in the event of a Change in Control.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 13, 2025